BSX · News · 20260809N
Revenue Performance and Mix
BOSTON SCIENTIFIC CORP · 2026-08-09 · Importance 36 · Surprise 14 · In source text
Boston Scientific reported second-quarter 2026 revenue of $5.44 billion, representing 7.5% year-over-year growth. International electrophysiology sales increased 23.1%, while international WATCHMAN sales increased 17.7%. U.S. growth headwinds affected WATCHMAN and electrophysiology performance despite the overall quarterly increase.
Key facts
- BOSTON SCIENTIFIC CORP reported Q2 adjusted EPS of $0.86 and revenue of $5.44 billion. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | unclear | realized | — | BOSTON SCIENTIFIC CORP reported Q2 adjusted EPS of $0.86 and revenue of $5.44 billion. |
| net_income | unclear | realized | — | BOSTON SCIENTIFIC CORP reported Q2 adjusted EPS of $0.86 and revenue of $5.44 billion. |